We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilis and Intrexon Collaborate on Rare Diseases

News   Jan 03, 2014

 
Agilis and Intrexon Collaborate on Rare Diseases
 
 
 

RELATED ARTICLES

A Killer on Your Skin

News

Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.

READ MORE

Immunotherapy Opportunities Lie in Glioma Molecular Landscape

News

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE